Updated Jul 16, 2026
Davis Jason has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $29K.
Davis Jason (as listed in SEC filings) serves as Chief Financial Officer of FibroBiologics, Inc. as of May 4, 2026. Public SEC documents identify this role but do not provide additional biographical details such as education, previous positions, or career history within the scope of the filings provided.
| Role | Chief Financial Officer |
|---|---|
| Notability | 12/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-03 | FBLG | FibroBiologics, Inc. | P — Open-market purchase | 70.0K | $0.41 | $29K |
Davis Jason (as listed in SEC filings) serves as Chief Financial Officer of FibroBiologics, Inc. as of May 4, 2026. Public SEC documents identify this role but do not provide additional biographical details such as education, previous positions, or career history within the scope of the filings provided.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($29K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Davis Jason profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.